Citations

Clear

4847 citation(s) found for "Yu, Eric".

Mutations Associated with Progression in Follicular Lymphoma Predict Inferior Outcomes in Newly Diagnosed Patients (Alliance 151303)
Krysiak, Kilannin, Trani, Lee , Gao, Feng , Geyer, Susan M. , Cashen, Amanda F. , Mehta-Shah, Neha, Lossos, Izidore S. , Leonard, John P. , Russler‐Germain, David A. , Ramirez, Cody A. , Mosior, Matthew , Watkins, Marcus P. , Gomez, Felicia , Skidmore, Zachary L. , Mehta–Shah, Neha , Kahl, Brad S. , Bartlett, Nancy L. , Hsi, Eric D. , Martin, Peter, Griffith, Malachi , Griffith, Obi L. , Fehniger, Todd A.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3543-3545

10.1182/blood-2022-157051 Get It

Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review
Tran, Diana , Rosta, Emily, Laidlaw, Alyshia , Rai, Manvir, Duran, Joana , Ammann, Eric M. , Fonseca, Rafaël

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 5212-5213

10.1182/blood-2022-165569 Get It

Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy
Hansen-Barkun, Christopher, Martel, Myriam , Douketis, James D. , Abraham, Neena S. , Liederman, Zachary , Kaplovitch, Eric , Spyropoulos, Alex C. , Majid, Almadi, Barkun, Alan , Barkun, Alan N , Schulman, Sam

Mayo Clinic

American Journal of Gastroenterology | November 26, 2022 | Volume: 118 | Issue: 5 | Pages: 812-819

10.14309/ajg.0000000000002076 | PMID 36434811 Get It

INTRODUCTION: The periprocedural management of patients with atrial fibrillation (AF) using a direct oral anticoagulant (DOAC) undergoing elective gastrointestinal (GI) endoscopic procedure remains uncertain. We investigated the safety of a standardized periprocedural DOAC management strategy. METHODS: The Periprocedural Anticoagulation Use for Surgery Evaluation cohort study enrolled adult patients receiving a DOAC (apixaban, rivaroxaban, or dabigatran) for AF scheduled for an elective procedure or surgery. This analysis addresses patients undergoing digestive endoscopy. Standardized periprocedural management consisted of DOAC interruption 1 day preendoscopy with resumption 1 day after procedure at low-moderate risk of bleeding or 2 days in case of a high bleeding risk. Thirty-day outcomes included GI bleeding, thromboembolic events, and mortality. RESULTS: Of 556 patients on a DOAC (mean [SD] age of 72.5 [8.6] years; 37.4% female; mean CHADS 2 score 1.7 [1.0]), 8.6% were also on American Society of Anesthesiology (ASA) and 0.7% on clopidogrel. Most of the patients underwent colonoscopies (63.3%) or gastroscopies (14.0%), with 18.9% having both on the same procedural day. The mean total duration of DOAC interruption was 3.9 ± 1.6 days. Four patients experienced an arterial thromboembolic event (0.7%, 0.3%–1.8%) within 24.2 ± 5.9 days of DOAC interruption. GI bleeding events occurred in 2.5% (1.4%–4.2%) within 11.1 ± 8.1 days (range: 0.6; 25.5 days) of endoscopy, with major GI bleeding in 0.9% (0.4%–2.1%). Three patients died (0.5%; 0.2%–1.6%) 15.6–22.3 days after the endoscopy. DISCUSSION: After a contemporary standardized periprocedural management strategy, patients with AF undergoing DOAC therapy interruption for elective digestive endoscopy experienced low rates of arterial thromboembolism and major bleeding.
A Review of the Role of Stereotactic Radiosurgery and Immunotherapy in the Management of Primary Central Nervous System Tumors
Lehrer, Eric J. , Sindhu, Kunal K. , Dickstein, Daniel R. , Cohen, Mira, Lazarev, Stanislav , Quiñones‐Hinojosa, Alfredo , Green, Sheryl , Sindhu, Kunal K , Dickstein, Daniel R , Jones, Brianna M. , Trifiletti, Daniel M.

Mayo Clinic

Biomedicines | November 21, 2022 | Volume: 10 | Issue: 11 | Pages: 2977

10.3390/biomedicines10112977 | PMID 36428546 Get It

Stereotactic radiosurgery (SRS) and immune checkpoint inhibitors (ICIs) are widely used in the management of brain metastases. These therapies are commonly administered concurrently; as SRS may enhance anti-tumor immunity and responsiveness to ICIs. However, the use of ICIs with and without SRS in the management of primary brain tumors remains a controversial topic. Meningiomas are the most common nonmalignant and extra-parenchymal brain tumor, which often respond well to surgery and radiotherapy. However, higher grade meningiomas tend to be resistant to these treatments, and the use of chemotherapy and targeted agents in this setting have yielded disappointing results. Thus, there is heightened interest in the utilization of ICIs. Glioblastoma is the most common malignant primary intraparenchymal brain tumor. It is associated with a grim prognosis with a median overall survival of approximately 20 months, despite optimal therapy. While SRS in the adjuvant setting, and ICI in the recurrent setting, have failed to demonstrate a survival benefit, SRS in the preoperative setting has the potential to enhance anti-tumor immunity and responsiveness to ICIs. Thus, these treatments represent an attractive option to add to the armamentarium of meningioma and glioblastoma management. In this review, we provide a detailed overview of the evidence supporting the use of ICIs and SRS in each of these settings.
Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance
Lyle, Melissa , Bhatia, Subir , Fenstad, Eric R. , Schroeder, Darrell R. , McCully, Robert B. , Lacy, Martha Q. , Feyereisn, Wayne L. , Feyereisn, Wayne L. , Lyle, Melissa A , Fenstad, Eric , Schroeder, Darrell

Mayo Clinic

Advances in Hematology | November 18, 2022 | Volume: 2022 | Issue: No issue available | Pages: 1-8

10.1155/2022/8918959 | PMID 36438612 Get It

Objective. To determine the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in patients with PH as well as precapillary PH. Methods. Olmsted County residents with PH, diagnosed between 1/1/1995 and 9/30/2017, were identified, and age and sex were matched to a normal control group. The PH group and normal control group were then cross-referenced with the Mayo Clinic MGUS database. Charts were reviewed to verify MGUS and PH. Heart catheterization data were then analyzed in these patients for reference to the gold standard for diagnosis. Results. There were 3419 patients diagnosed with PH by echocardiography between 1995 and 2017 in Olmsted County that met the criteria of our study. When the PH group (N = 3313) was matched to a normal control group (3313), a diagnosis of MGUS was significantly associated with PH 10.2% (OR = l.84 [95% CI 1.5–2.2], p < 0.001 ), compared with controls 5.8% based on echo diagnosis. Using heart catheterization data (484 patients), a diagnosis of MGUS was associated with PH 13.0% (OR = 3.94 [95% CI 2.28–6.82], p < 0.001 ). For pulmonary artery hypertension (N = 222), a diagnosis of MGUS was associated with PH at similar 12.2% (OR = 4.50 [95%CI 1.86–10.90], p < 0.001 . Conclusions. There is a higher prevalence of MGUS in patients with PH and precapillary PH compared with normal controls. This association cannot be explained fully by other underlying diagnoses associated with PH. Assessing for this in patients with PH of unclear etiology may be reasonable in the workup of patients found to have PH.
Achieving a Representative Sample of Asian Americans in Biomedical Research Through Community-Based Approaches: Comparing Demographic Data in the All of Us Research Program With the American Community Survey
Randal, Fornessa T., Lozano, Paula , Qi, Siya, Maene, Chieko, Shah, Sameep , Mo, Yicklun, Ratsimbazafy, Francis, Boerwinkle, Eric , Cicek, Mine , Loperena, Roxana , Mayo, Kelsey , Mockrin, Stephen, Ohno‐Machado, Lucila , Schully, Sheri D. , Ramirez, Andrea H. , Aschebrook‐Kilfoy, Briseis , Ahsan, Habibul , Lam, Helen , Kim, Karen E., Clark, Cheryl R. , Cohn, Elizabeth, Gebo, Kelly A , Kim, Karen E.

Mayo Clinic

Journal of Transcultural Nursing | November 18, 2022 | Volume: 34 | Issue: 1 | Pages: 59-67

10.1177/10436596221130796 | PMID 36398985 Get It

Background: Underrepresented persons are often not included in biomedical research. It is unknown if the general Asian American population is being represented in All of Us . The purpose of this study was to compare the Asian demographic data in the All of Us cohort with the Asian nationally representative data from the American Community Survey. Method: Demographic characteristics and health literacy of Asians in All of Us were examined. Findings were qualitatively compared with the Asian data in the 2019 American Community Survey 1-year estimate. Results: Compared with the national composition of Asians, less All of Us participants were born outside the United States (64% vs 79%), were younger, and had higher levels of education (76% vs 52%). Over 60% of All of Us participants reported high levels of health literacy. Conclusion: This study had implications for the development of strategies that ensure diverse populations are represented in biomedical research.